Alnylam Pharmaceuticals
ALNY
#544
Rank
A$64.90 B
Marketcap
A$489.39
Share price
1.73%
Change (1 day)
23.88%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company